| Literature DB >> 21738856 |
Chodchanok Vijarnsorn1, Duangmanee Laohaprasitiporn, Kritvikrom Durongpisitkul, Prakul Chantong, Jarupim Soongswang, Paweena Cheungsomprasong, Apichart Nana, Somchai Sriyoschati, Thawon Subtaweesin, Punnarerk Thongcharoen, Ungkab Prakanrattana, Jiraporn Krobprachya, Julaporn Pooliam.
Abstract
Objectives. To determine in-hospital mortality and complications of cardiac surgery in pediatric patients and identify predictors of hospital mortality. Methods. Records of pediatric patients who had undergone cardiac surgery in 2005 were reviewed retrospectively. The risk adjustment for congenital heart surgery (RACHS-1) method, the Aristotle basic complexity score (ABC score), and the Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgery Mortality score (STS-EACTS score) were used as measures. Potential predictors were analyzed by risk analysis. Results. 230 pediatric patients had undergone congenital cardiac surgery. Overall, the mortality discharge was 6.1%. From the ROC curve of the RACHS-1, the ABC level, and the STS-EACTS categories, the validities were determined to be 0.78, 0.74, and 0.67, respectively. Mortality risks were found at the high complexity levels of the three tools, bypass time >85 min, and cross clamp time >60 min. Common morbidities were postoperative pyrexia, bleeding, and pleural effusion. Conclusions. Overall mortality and morbidities were 6.1%. The RACHS-1 method, ABC score, and STS-EACTS score were helpful for risk stratification.Entities:
Year: 2011 PMID: 21738856 PMCID: PMC3123846 DOI: 10.4061/2011/254321
Source DB: PubMed Journal: Cardiol Res Pract ISSN: 2090-0597 Impact factor: 1.866
Figure 1Flow chart of participants through the study.
Patients' baseline characteristics in the present study (n = 230).
| Characteristics | |
|---|---|
| Sex; | |
| Male | 126 (54.8) |
| Female | 104 (45.2) |
| Age at presentation (years); median (range) | 0.6 (0–14.5) |
| Age at surgery (years); median (range) | 4.3 (0.02–15) |
| <30 days; | 5 (2.7) |
| 31 days to 1 year; | 53 (23.4) |
| ≥1 year; | 172 (73.9) |
| Definite genetic syndrome; | 7 (3.0) |
| Down syndrome | 6 |
| VATER association | 1 |
Surgical procedures in the present study (n = 230).
| Procedures | |
|---|---|
| VSD patch closure | 70 (30.4) |
| TOF repair (transannular patch technique) | 37 (16.1) |
| Systemic to pulmonary shunt | 27 (11.8) |
| AVC correction | 17 (7.5) |
| ASD closure | 14 (6.1) |
| Fontan operation | 10 (4.4) |
| Rastelli operation (RV-PA conduit) | 8 (3.5) |
| Glenn operation | 8 (3.5) |
| Arterial switch operation (ASO) + VSD closure | 5 (2.1) |
| Pulmonary artery banding (PAB) | 4 (1.7) |
| Ebstein's repair | 4 (1.7) |
| PDA ligation | 4 (1.7) |
| Coarctation repair (end to end anastomosis) | |
| Coarctectomy + PDA ligation | 4 (1.7) |
| Coarctectomy + PA banding | 2 (0.9) |
| Truncus repair | 2 (0.9) |
| Mitral valve annuloplasty/replacement | 2 (0.9) |
| Pulmonary valvulotomy | 2 (0.9) |
| PDA ligation + remove vegetation | 2 (0.9) |
| Arterial switch operation (ASO) | 2 (0.9) |
| PAVC repair | 1 (0.4) |
| Glenn operation + valve repair | 1 (0.4) |
| Hemifontan operation | 1 (0.4) |
| Atrial switch operation | 1 (0.4) |
| Ross operation | 1 (0.4) |
| Tricuspid valve repositioning in neonatal Ebstein | 1 (0.4) |
VSD: ventricular septal defect, ASD: atrial septal defect, PDA: patent ductus arteriosus, AVC: atrioventricular canal, TOF: tetralogy of Fallot, RV: right ventricle, PA: pulmonary artery, ASO: arterial switch operation, and PAVC: partial atrioventricular canal.
Distribution of cases by the RACHS-1 risk categories, the Aristotle basic complexity levels, and STS-EACTS mortality categories.
| RACHS-1 level | ABC level | ABC score | Mean ABC score ± SD | STS-EACTS category | STS-EACTS score | Mean STS-EACTS score ± SD | |||
|---|---|---|---|---|---|---|---|---|---|
| I | 22 (9.6) | I | 1.5–5.9 | 3.2 ± 6.6 | 23 (10) | I | 0.1–0.3 | 0.19 ± 0.05 | 90 (39.1) |
| II | 118 (51.3) | II | 6–7.9 | 6.1 ± 0.3 | 106 (46.1) | II | 0.4–0.7 | 0.51 ± 0.06 | 64 (27.8) |
| III | 81 (35.2) | II | 8–9.9 | 8.4 ± 0.6 | 80 (34.8) | III | 0.8–1.2 | 0.84 ± 0.09 | 28 (12.2) |
| IV | 8 (3.5) | IV | 10–15 | 10.3 ± 0.5 | 21 (9.1) | IV | 1.3–2.6 | 1.61 ± 0.23 | 48 (20.9) |
| V | 1 (0.4) | V | 2.7–5 | — | 0 (0) | ||||
| VI | 0 (0) | ||||||||
| Total | 230 | 7.1 ± 1.9 | 230 | 0.65 ± 0.54 | 230 | ||||
Figure 2Mortality rate by RACHS-1 in the present study (n = 230).
Figure 3Mortality rate by ABC level in the present study (n = 230).
Summary of discharge mortality cases.
| No. | Age (years) | Sex | Diagnosis | Surgical type | CPB time (min) | AoX time (min) | Death at PO day | RACHS-1 level | Cause |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.23 | Male | Primum ASD | Total repair | 101 | 68 | 7 | II | Cardiac tamponade |
| 2 | 10 | Female | UVH | Fontan | 200 | 49 | 1 | III | Low output, VT, and |
| 3 | 11.9 | Male | TOF | Total repair | 104 | 70 | 47 | II | P. auruginosa pneumonia, MRSA Sepsis, IE, and diaphragm paralysis |
| 4 | 3.9 | Female | Unbalance AVC and PS | Fontan | 240 | 0 | 0 | III | Low output |
| 5 | 1.97 | Male | UVH and PS | Central shunt | 94 | 0 | 1 | III | Low output |
| 6 | 0.36 | Female | CAVC | Total repair | 99 | 76 | 87 | III | A. buamnii pneumonia, P. auruginosa sepsis |
| 7 | 4.74 | Female | UVH, PS | Fontan | 86 | 0 | 2 | III | Low output |
| 8 | 0.51 | Male | CAVC | Total repair | 90 | 70 | 45 | III | Sepsis, DIC, and residual shunt |
| 9 | 0.7 | Female | CAVC | Total repair | 160 | 60 | 2 | III | PHT crisis |
| 10 | 0.86 | Male | CAVC | Total repair | 174 | 127 | 40 | III | Candida sepsis |
| 11 | 0.04 | Male | Ebstein anomaly and PS | Pulmonic valvluotomy, TVR repair | 43 | 0 | 1 | V | Low output |
| 12 | 0.5 | Male | CAVC | Total repair | 145 | 77 | 1 | III | Low output, and VT |
| 13 | 2.24 | Male | TGA, VSD | ASO and VSD closure | 134 | 70 | 2 | IV | Low output |
| 14 | 0.13 | Female | Truncus arteriosus | Total repair | 156 | 68 | 0 | IV | Low output |
CPB: cardiopulmonary bypass, AoX: aortic clamp, ASD: atrial septal defect, UVH: univentricular heart, TOF: tetralogy of Fallot, AVC: atrioventricular canal, CAVC: complete atrioventricular repair, PS: pulmonary stenosis, TGA: transposition of great arteries, PHT crisis: pulmonary hypertensive crisis, VT: ventricular tachycardia, DIC: disseminated intravascular coagulopathy.
Univariate analysis of independent variables in the present study (n = 230).
| Variables | Alive discharge | Mortality discharge | |
|---|---|---|---|
| Sex; | |||
| Male | 119 (94.4%) | 7 (5.6%) | .925 |
| Female | 97 (93.3%) | 7 (6.7%) | |
| Age (years); median (range) | 3.18 (0.03–15.29) | 1.05 (0.04–11.93) | .069 |
| RACHS-1 level; | |||
| 1 | 22 (100%) | 0 (0%) | <.001 |
| 2 | 116 (98.3%) | 2 (1.7%) | |
| 3 | 72 (88.9%) | 9 (11.1%) | |
| 4 | 6 (75%) | 2 (25%) | |
| 5 | 0 (0%) | 1 (100%) | |
| 6 | — | — | |
| ABC level; | <.001 | ||
| 1 | 22 (95.7%) | 1 (4.3%) | |
| 2 | 105 (99.1%) | 1 (0.9%) | |
| 3 | 71 (88.8%) | 9 (11.2%) | |
| 4 | 18 (85.8%) | 3 (14.2%) | |
| STS-EACTS mortality categories; | .01 | ||
| 1 | 89 (98.9) | 1 (1.1) | |
| 2 | 60 (93.8) | 4 (6.2) | |
| 3 | 23 (82.2) | 5 (17.8) | |
| 4 | 44 (91.7) | 4 (8.3) | |
| 5 | — | — | |
| Bypass time (min.); median (range) | 71 (0–289) | 119 (43–240) | .002 |
| Cross clamp time (min); median (range) | 37 (0–148) | 69 (0–127) | .019 |
Values are expressed as the number of patients (%) and median (range).
Risk of death estimated by univariate and multivariate analysis using categorical data in the present study.
| Variables | Alive discharge ( | Mortality discharge ( | Crude odds ratio | Adjusted odds ratio |
|---|---|---|---|---|
| Age at operation; | ||||
| <30 days | 7 (87.5) | 1 (12.5) | 1 | |
| >30 days | 209 (94.1) | 13 (5.9) | 0.4 (0.1–3.8) | |
| RACHS-1 level; | ||||
| 1–3 | 210 (95.0) | 11 (5.0) | 1 | 1 |
| 4–6 | 6 (66.7) | 3 (33.3) | 9.5 (2.1–43.3) | 10.0 (1.6–62.0)* |
| ABC level; | ||||
| 1-2 | 127 (98.5) | 2 (1.5) | 1 | |
| 3-4 | 89 (88.1) | 12 (11.9) | 8.5 (1.9–39.1) | |
| STS-EACTS mortality category | ||||
| 1-2 | 149 | 5 | 1 | |
| 3–5 | 67 | 9 | 4.1 (1.2–12.3) | |
| Bypass time (min.); | ||||
| ≤85 | 125 (99.2) | 1 (0.8) | 1 | |
| >85 | 82 (86.3) | 13 (13.7) | 19.8 (2.5–154.4) | |
| Cross clamp time (min.); | ||||
| ≤60 | 154 (97.5) | 4 (2.5) | 1 | |
| >60 | 49 (86.0) | 8 (14.0) | 6.3 (1.8–21.8) |
*P value = .013, **P-value = .001.
Major postoperative complications and morbidities (n = 230).
| Variables | |
|---|---|
| Postoperative pyrexia | 99 (43.0) |
| Bleeding, cardiac tamponade, and unstable hemodynamic requiring reoperation | 22 (9.6) |
| Pleural effusion and chylothorax | 20 (8.6) |
| Serious cardiac arrhythmia (total events) | 20 (8.7) |
| (i) Junctional ectopic tachycardia | 4 (2.3) |
| (ii) Autonomic ectopic tachycardia | 2 (0.8) |
| (iii) Supraventricular tachycardia | 2 (0.8) |
| (iv) Ventricular tachycardia | 3 (2.3) |
| (v) Ventricular fibrillation | 1 (0.4) |
| (vi) Junctional rhythm (required temporary pacing) | 1 (1.3) |
| (vii) Complete heart block | 6 (2.8) |
| Required reintubation | 12 (5.2) |
| Renal failure required peritoneal dialysis | 6 (2.6) |
| Pneumothorax (needed more ICD) | 4 (1.7) |
| Wound infection and mediastinitis | 1 (0.5) |
| Neurological deficit | 0 (0) |
| Anticoagulation complication | 0 (0) |
ICD: intercostal drainage, CPR: cardiopulmonary resuscitation.
Figure 4Mortality rate by STS-EACTS mortality categories in the present study (n = 230).